NASDAQ: ANTX - AN2 Therapeutics, Inc.

Yield per half year: -57.66%
Sector: Healthcare

Share chart AN2 Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

AN2 Therapeutics, Inc., биофармацевтическая компания клинической стадии, занимается разработкой методов лечения редких, хронических и серьезных инфекционных заболеваний. Компания разрабатывает эпетраборол, пероральный препарат для приема один раз в день для пациентов с хроническим нетуберкулезным микобактериальным заболеванием легких. Компания была зарегистрирована в 2017 году и имеет штаб-квартиру в Менло-Парке, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Цена ао 1.08
Сайт https://www.an2therapeutics.com
P/BV 1.88
EV/EBITDA 1.08
ISIN US0373261058
Число акций ао 0.0236 млрд
EBITDA -0.0052
Валюта usd
IPO date 2022-03-25
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: 0% (1.05)
Change price per week: +0.9615% (1.04)
Change price per month: +0.9615% (1.04)
Change price per 3 month: -61.4% (2.72)
Change price per half year: -57.66% (2.48)
Change price per year: -92.95% (14.89)
Change price per year to date: -93.46% (16.06)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 3.94 4
P/E 0 0
EV/EBITDA -6.84 0
Total: 2.75

Efficiency

Title Value Grade
ROA, % -46.66 0
ROE, % -51.91 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.000761 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 1239.13 10
Yield EPS, % 812.16 10
Total: 8
More

Institutions Volume Share, %
RA Capital Management, L.P. 5551295 18.65
Tcg Crossover Management, Llc 2678209 9
BVF Inc. 1563963 5.25
Citadel Advisors Llc 1556842 5.23
Frazier Life Sciences Management, L.P. 1388889 4.67
Janus Henderson Group PLC 1279975 4.3
Avidity Partners Management, LP 1140000 3.83
Vanguard Group Inc 1052591 3.54
Adage Capital Partners GP L.L.C. 900672 3.03
Octagon Capital Advisors LP 664575 2.23

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.00413 36.318555985322 1.54048



Head Job title Payment Year of birth
Mr. Joseph S. Zakrzewski Co-Founder & Chairman of the Board 77.58k 1962 (62 years)
Mr. Eric E. Easom Co-Founder, CEO, President & Chairman of the Board 697.72k 1968 (56 years)
Ms. Lucy O. Day CPA CFO, Principal Financial Officer & Principal Accounting Officer 391.02k 1959 (65 years)
Dr. George Harrison Talbot FACP, M.D. Co-Founder & Senior Clinical Advisor N/A 1948 (76 years)
Dr. Michael R. K. Alley Ph.D. Co-Founder & Head of Biology N/A
Dr. Sanjay Chanda Ph.D. Chief Development Officer N/A 1965 (59 years)
Mr. Kevin Krause B.S., M.B.A. Chief Strategy Officer N/A 1975 (49 years)
Ms. Jennifer Huber Senior Vice President of Regulatory Affairs & Quality N/A
Mr. Joshua Eizen J.D. Chief Legal Officer & Secretary 439.12k 1978 (46 years)

Address: United States, Menlo Park. CA, 1800 El Camino Real - open in Google maps, open in Yandex maps
Website: https://www.an2therapeutics.com